influenza
viru
iav
member
orthomyxovirida
famili
compris
neg
sens
rna
genom
eight
segment
encapsul
nucleoprotein
np
encod
known
protein
iav
classifi
basi
antigen
differ
surfac
glycoprotein
hemagglutinin
ha
neuraminidas
ha
neuraminidas
subtyp
describ
date
infect
iav
protein
interact
numer
host
cellular
protein
variou
subcellular
compart
use
cellular
machineri
viru
replic
deciph
host
factor
promot
inhibit
viru
replic
provid
import
insight
viral
pathogen
pave
way
develop
new
influenza
approach
among
influenza
viral
protein
np
one
structur
protein
present
abund
insid
virion
form
complex
polymeras
protein
viral
rna
vrna
genom
np
multifunct
protein
play
import
role
transcript
replic
morphogenesi
bud
viru
henc
pertin
np
interact
multitud
host
protein
modul
function
benefit
viru
identifi
host
protein
interact
np
viral
protein
iav
two
technolog
extens
use
yeast
system
biochem
purificationm
recent
develop
rna
interfer
rnai
base
screen
techniqu
wide
use
deduc
host
cellular
pathway
host
factor
involv
iav
replic
present
studi
use
system
identifi
human
refer
subsequ
novel
interact
partner
iav
np
ubiquit
present
isoform
togeth
protein
keep
cytoskeleton
intact
four
isoform
human
report
present
cell
protrus
cell
adhes
numer
cell
type
share
nucleotid
homolog
similar
amino
acid
sequenc
known
found
tight
junction
mount
evid
actinin
critic
cytoskelet
compon
interact
mani
viral
protein
shown
actinin
interact
protein
hepat
c
viru
play
import
role
hepat
c
viru
rna
replic
note
worthili
interact
vpx
protein
simian
immunodefici
viru
play
essenti
role
transport
vpx
protein
host
cellular
nucleu
aid
nuclear
import
complex
identifi
host
novel
influenza
viru
partner
interact
np
valid
mammalian
cell
system
shown
conserv
across
sever
iav
subtyp
includ
pandem
viru
report
knockdown
express
reduc
viral
gene
transcript
replic
indic
play
crucial
role
influenza
viral
replic
result
also
suggest
interact
may
aid
nuclear
local
np
viral
infect
thu
emphas
physiolog
relev
associ
henc
present
studi
uncov
central
role
interact
iav
nucleoprotein
host
cytoskelet
protein
viral
life
cycl
identifi
potenti
interact
partner
np
iav
screen
human
lung
cdna
librari
use
np
bait
clone
encod
amino
acid
obtain
posit
interactor
screen
confirm
blast
analysi
fig
b
human
cdna
clone
activ
domain
vector
bait
vector
strain
yeast
furthermor
test
posit
histidin
prototrophi
activ
fig
confirm
influenza
nucleoprotein
interact
protein
interact
valid
perform
assay
np
protein
express
use
vitro
coupl
rabbit
reticulocyt
lysat
system
presenc
reaction
shown
fig
valid
interact
np
confirm
interact
mammalian
cell
cell
transfect
np
express
construct
either
alon
togeth
np
express
confirm
shown
fig
top
two
panel
immunoprecipit
analysi
use
serum
follow
immunoblot
serm
confirm
interact
np
fig
bottom
panel
collect
result
indic
inde
interact
np
yeast
system
mammalian
cell
determin
whether
np
interact
iav
infect
lung
epitheli
cell
infect
apuerto
viru
multipl
infect
moi
hour
pi
cell
harvest
lysat
subject
immunoprecipit
use
antibodi
specif
np
np
viru
reciproc
np
fig
panel
figur
panel
also
show
immunoprecipit
np
western
blot
serum
immunoprecipit
western
blot
serum
respect
shown
fig
panel
interact
anoth
influenza
viral
protein
infect
cell
thu
authent
specif
interact
np
significantli
interact
also
confirm
cell
infect
iav
subtyp
avian
human
origin
includ
highli
pathogen
avian
influenza
viru
pandem
viru
fig
suggest
interact
conserv
across
multipl
subtyp
influenza
virus
determin
site
kinet
np
infect
perform
immunofluoresc
studi
accordingli
cell
infect
moi
harvest
h
pi
subject
immunofluoresc
analysi
shown
fig
np
majorli
around
nucleu
h
pi
h
pi
cytosol
fig
cell
shown
fig
data
collect
five
differ
independ
cell
shown
fig
repres
graphic
pearson
coeffici
use
quantit
measur
degre
np
explor
signific
examin
effect
deplet
np
local
cell
transfect
either
nontarget
nt
short
interf
rna
sirna
sirna
h
infect
moi
h
subsequ
subcellular
fraction
nuclear
cytoplasm
fraction
check
presenc
np
western
blot
analysi
intriguingli
silenc
express
led
signific
reduct
amount
np
protein
nuclear
fraction
compar
control
fig
analyz
deplet
cell
treat
sirna
follow
infect
moi
observ
significantli
reduc
local
np
nucleu
compar
control
sirna
use
immunofluoresc
assay
fig
viabil
cell
determin
h
pi
measur
cytotox
sirna
versu
nt
sirna
result
illustr
fig
show
specif
cell
viabl
compar
transfect
reagent
control
wortmannin
inhibitor
known
caus
dissoci
cytoskeleton
steadi
transloc
nucleu
analyz
influenc
subcellular
local
np
local
treat
cell
either
dimethylsulfoxid
dmso
wortmannin
h
follow
infect
moi
assess
np
local
use
immunofluoresc
assay
figur
b
show
increas
retent
np
nucleu
cell
even
h
pi
compar
cell
np
show
local
nuclear
cytoplasm
compart
effect
wortmannin
dissoci
cytoskeleton
transloc
nucleu
shown
fig
result
indic
np
iav
interact
well
cellular
milieu
next
aim
investig
effect
iav
infect
express
accordingli
examin
effect
viru
dose
durat
infect
mrna
protein
express
pi
signific
progress
increas
level
mrna
protein
observ
upon
infect
cell
viru
increas
moi
fig
b
addit
increas
h
observ
rel
mrna
level
cell
infect
given
moi
fig
increas
mrna
level
also
correspond
elev
level
protein
express
fig
collect
result
suggest
viru
dose
durat
infect
express
protein
mrna
level
understand
physiolog
relev
interact
examin
consequ
inhibit
express
viral
replic
cell
treat
either
nt
sirna
h
infect
viru
silenc
express
confirm
quantit
pcr
western
blot
analys
fig
mrna
vrna
level
hallmark
viral
gene
transcript
replic
measur
paramet
quantit
pcr
silenc
led
signific
reduct
level
np
mrna
vrna
cell
fig
c
interestingli
maximum
reduct
approxim
observ
mrna
vrna
level
respect
h
pi
consist
maximum
silenc
mrna
level
observ
time
point
pi
howev
absenc
iav
infect
cell
signific
effect
mrna
level
h
pi
fig
h
pi
rel
mrna
level
decreas
almost
deplet
cell
may
attribut
reduct
viral
titer
fig
thu
suggest
deplet
profound
effect
np
mrna
vrna
specif
earli
time
point
view
signific
effect
wortmannin
challeng
cell
wortmannin
h
follow
infect
viru
moi
h
agreement
previou
observ
signific
decreas
observ
np
mrna
level
wortmannin
cell
compar
dimethylsulfoxid
cell
fig
assess
role
viru
replic
detail
investig
effect
iav
replicas
activ
cell
treat
either
nt
sirna
sirna
follow
plasmid
encod
polymeras
complex
gene
pa
np
conjunct
report
plasmid
contain
utr
segment
upstream
luciferas
gene
driven
human
rna
pol
promot
figur
show
reduct
replicas
activ
upon
silenc
compar
nt
sirna
treatment
addit
shown
fig
np
level
reduc
deplet
cell
result
strongli
suggest
essenti
iav
replic
express
appear
crucial
viral
transcript
replic
next
studi
effect
express
viral
protein
level
western
blot
analysi
whole
cell
extract
infect
cell
demonstr
substanti
lower
express
np
express
knock
fig
assess
effect
viral
replic
greater
detail
perform
plaqu
assay
accordingli
cell
transfect
either
nt
sirna
sirna
follow
infect
influenza
viru
moi
agreement
observ
viral
replicas
assay
signific
decreas
viral
titer
especi
h
pi
supernat
cell
treat
sirna
compar
treat
nt
sirna
furthermor
silenc
express
confirm
western
blot
analysi
fig
complement
observ
titer
iav
remark
decreas
treat
cell
wortmannin
follow
infect
viru
moi
fig
next
aim
determin
effect
deplet
infect
cell
viru
infect
h
pi
compar
cell
infect
control
h
pi
respect
cell
infect
sirna
treatment
fig
silenc
two
time
point
shown
fig
c
find
suggest
requir
viral
protein
synthesi
replic
take
find
togeth
present
studi
unravel
novel
crucial
role
variou
stage
iav
life
cycl
includ
viral
transcript
translat
viral
protein
viral
replic
exploit
host
cellular
machineri
key
success
replic
iav
accordingli
viru
employ
protein
interact
manipul
function
host
protein
agreement
concept
sever
studi
shown
influenza
np
interact
number
host
cell
protein
includ
actin
importin
screen
analysi
tradit
method
choic
explor
interact
partner
critic
protein
valid
modifi
improv
make
util
compar
convent
method
rnai
screen
begin
employ
map
cellular
interactom
import
protein
use
rnai
screen
human
gene
identifi
potenti
host
factor
involv
influenza
viru
replic
howev
interact
viral
host
protein
valid
condit
infect
physiolog
relev
unravel
contrast
screen
np
bait
protein
reveal
karyopherinalpha
clusterin
uniqu
partner
function
signific
interact
use
system
identifi
interact
partner
np
first
time
present
studi
provid
evid
key
cytoskelet
compon
interact
np
facilit
intercompartment
local
promot
viral
replic
valid
interact
translat
system
transfect
mammalian
cell
well
cell
found
interact
well
conserv
across
differ
subtyp
influenza
virus
rang
season
virus
current
pandem
strain
signifi
interact
np
import
irrespect
iav
strain
well
establish
virus
manipul
actin
cytoskeleton
facilit
viral
entri
endocytosi
replic
egress
spread
thu
depend
molecular
interact
host
cytoskelet
protein
hepat
c
viru
coronavirus
exploit
cytoskeleton
replic
bud
respect
measl
viru
exploit
cytoskeleton
enter
host
cell
transport
core
protein
perinuclear
region
replic
digard
et
al
identifi
host
protein
interact
iav
np
facilit
cytosol
retent
later
stage
infect
protein
amino
acid
highli
conserv
protein
belong
spectrin
famili
contain
calpolin
homolog
domain
follow
spectrin
repeat
connect
actin
cytoskeleton
membran
focal
adhes
thu
regul
cell
motil
clone
identifi
screen
contain
amino
acid
region
human
correspond
spectrin
repeat
protein
emphas
signific
repeat
regul
host
cytoskeleton
also
crosstalk
recent
also
shown
function
coactiv
regul
transcript
network
control
cell
growth
function
make
protein
indispens
cell
surviv
therefor
advantag
protein
interact
cytoskeleton
protein
replic
cell
next
investig
cellular
local
interact
infect
found
protein
primarili
around
nucleu
cell
h
pi
howev
h
pi
protein
predominantli
cytoplasm
upon
iav
infect
observ
accumul
increasingli
around
nucleu
white
arrow
compar
uninfect
cell
yellow
arrow
fig
f
base
observ
hypothes
increas
express
may
attribut
transport
np
across
nucleu
observ
two
protein
cytoplasm
examin
chang
local
np
absenc
notabl
np
retain
cytoplasm
reduc
transport
nucleu
support
observ
known
shuttl
nucleu
cytoplasm
import
nucleu
nuclear
pore
complex
manner
therefor
data
suggest
might
involv
facilit
shuttl
npviral
ribonucleoprotein
across
subcellular
compart
promot
viru
replic
known
interact
actin
within
cytoskelet
framework
possibl
shuttl
np
nuclear
cytoplasm
compart
may
involv
format
ternari
complex
np
actin
retent
np
insid
nucleu
result
migrat
cytoskeleton
nucleu
treat
cell
wortmannin
further
hypothesi
possibl
remain
examin
care
interestingli
viru
dose
well
durat
infect
elev
express
consist
observ
show
viral
infect
alter
express
host
cell
protein
involv
protein
synthesi
transcript
regul
signal
increas
express
attribut
transport
np
across
nucleu
also
shown
silenc
notabl
reduct
vrna
mrna
level
iav
np
protein
level
np
suggest
like
role
iav
replic
transcript
conceiv
reduct
viral
titer
lead
commensur
decreas
viral
protein
translat
deplet
cell
reduct
replicas
activ
polymeras
deplet
cell
strengthen
hypothesi
play
direct
indirect
role
replic
influenza
life
cycl
also
consist
previou
studi
show
interact
sever
transcript
factor
includ
subunit
transcript
factor
nucleu
cytoplasm
mrna
process
studi
need
defin
molecular
mechan
interact
control
viral
replic
transcript
understand
mechan
may
provid
insight
respect
develop
novel
therapeut
cell
cell
obtain
american
type
cultur
collect
atcc
manassa
va
usa
maintain
acord
manufactur
instruct
apuerto
influenza
viru
strain
use
moi
unless
specifi
otherwis
influenza
viru
strain
use
experi
list
tabl
np
gene
isol
clone
plasmid
use
bait
vector
studi
human
gene
clone
pcmx
plasmid
provid
kao
depart
biochemistri
school
medicin
case
western
reserv
univers
cleveland
oh
usa
serum
obtain
immunolog
pathogenesi
branch
influenza
divis
centr
diseas
control
prevent
atlanta
ga
usa
serum
purchas
enzo
life
scienc
inc
farmingdal
ny
usa
sera
purchas
santa
cruz
biotechnolog
inc
santa
cruz
ca
usa
serum
purchas
st
loui
mo
usa
pool
sirna
purchas
santa
cruz
biotechnolog
santa
cruz
ca
usa
renilla
luciferas
assay
system
kit
obtain
promega
corp
madison
wi
usa
lex
base
screen
system
hybrid
hunter
version
f
compris
saccharomyc
cerevisia
strain
mata
phyblexazeo
bind
domain
activ
domain
vector
respect
human
lung
cdna
librari
clone
purchas
invitrogen
carlsbad
ca
usa
screen
perform
accord
manufactur
instruct
bait
plasmid
construct
clone
iav
np
code
sequenc
lexa
dna
bind
domain
phyblexazeo
cdna
librari
select
activ
two
report
gene
lacz
strength
interact
select
assess
abil
grow
zeo
yc
media
supplement
mm
competit
inhibitor
posit
filter
activ
assay
plasmid
isol
posit
shuttl
escherichia
coli
sequenc
sequenc
obtain
analyz
blast
identifi
insert
use
posit
control
phyblexazeo
use
neg
control
librari
screen
cell
treat
lysi
buffer
mm
tri
ph
mm
nacl
mm
edta
triton
supplement
complet
mixtur
purchas
santa
cruz
biotechnolog
lysat
thu
obtain
subject
sdspage
cell
harvest
mention
lysi
buffer
cell
lysat
incub
primari
antibodi
overnight
follow
incub
protein
dynabead
purchas
invitrogen
bead
wash
three
time
chill
naclpi
resuspend
laemmli
buffer
boil
min
bead
spin
supernat
subject
western
blot
cell
seed
dish
adher
treat
either
nt
specif
sirna
h
subsequ
bromid
solutionwel
ad
incub
min
allow
format
formazan
medium
remov
dimethylsulfoxid
ad
well
dissolv
formazan
absorb
measur
elisa
plate
reader
test
wavelength
nm
refer
wavelength
nm
obtain
sampl
signal
dimethylsulfoxid
use
refer
cell
infect
influenza
viru
moi
fix
differ
time
point
naclpi
paraformaldehyd
min
room
temperatur
permeabil
triton
naclpi
min
room
temperatur
block
naclpi
contain
bovin
serum
albumin
immunostain
perform
use
mous
rabbit
sera
wash
away
naclpi
contain
incub
goat
alexa
goat
alexa
conjug
sera
purchas
invitrogen
nucleu
stain
dapi
slide
observ
magnif
use
confoc
microscop
nikon
tokyo
japan
total
rna
cell
extract
use
rneasi
mini
kit
qiagen
hilden
germani
rna
use
thermoscript
system
invitrogen
volum
dnase
treatment
result
cdna
dilut
use
sybr
green
sa
bioscienc
valencia
ca
usa
base
pcr
reaction
volum
use
pcr
instrument
stratagen
santa
clara
ca
usa
primer
use
primer
forward
gtt
ctc
gat
ctg
tgt
gcc
tg
revers
gac
ctg
ctg
ctg
gac
cc
housekeep
gene
primer
forward
acc
aac
tgg
gac
gac
atg
gag
aaa
revers
tag
cac
agc
ctg
gat
agc
aac
gta
gapdh
primer
forward
tca
ctg
cca
ccc
aga
aga
ctg
revers
gga
tga
cct
tgc
cca
cag
c
np
vrna
primer
ctc
gtc
gct
tat
gac
aaa
gaa
g
np
gene
primer
mrna
forward
ctc
gtc
gct
tat
gac
aaa
gaa
g
revers
aga
tca
tca
tgt
gag
tca
gac
gene
primer
mrna
forward
cag
gac
ata
ctg
atg
agg
atg
revers
gtt
tca
gag
act
cga
act
gtg
use
normal
ct
valu
obtain
pcr
reaction
use
calcul
fold
chang
compar
uninfect
sampl
use
method
cell
plate
densiti
per
well
plate
transfect
nm
nt
sirna
sirna
target
h
infect
moi
sirna
concentr
use
optim
nm
cell
cell
harvest
h
pi
analyz
western
blot
respect
antibodi
cell
treat
nt
sirna
infect
moi
supernat
collect
h
analyz
viru
growth
plaqu
assay
use
canin
kidney
mdck
cell
genom
segment
pa
np
deriv
clone
lung
epitheli
cell
nt
sirna
sirna
compon
influenza
polymeras
pa
np
transfect
along
luciferas
report
plasmid
contain
noncod
sequenc
segment
iav
luciferas
gene
driven
pol
h
sirna
cell
infect
iav
wash
naclpi
cell
fraction
cytosol
membran
nuclei
cytoskeleton
use
q
proteom
cell
compart
kit
qiagen
accord
manufactur
instruct
fraction
subject
western
blot
fraction
analyz
detect
gapdh
protein
control
cell
fraction
procedur
follow
respect
antibodi
membran
data
express
mean
se
mean
compar
analysi
varianc
follow
fisher
protect
least
signific
differ
test
assess
specif
group
differ
p
consid
statist
signific
skl
ss
hf
conceiv
design
experi
ss
akm
hn
st
perform
experi
skl
ss
ss
akm
pg
jrp
jbb
analyz
data
rod
jmk
njc
rbl
wrote
paper
ss
akm
ss
skl
contribut
reagent
materi
analysi
tool
